Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Open Access Guideline
Open Access Guideline
Postgraduate Thesis Guideline
Postgraduate Thesis Guideline
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
CardioMEA: comprehensive data analysis platform for studying cardiac diseases and drug responses
Download
fphys-1-1472126.pdf
Date
2024-01-01
Author
Lee, Jihyun
Duperrex, Eliane
El-Battrawy, Ibrahim
Hohn, Alyssa
Saguner, Ardan M.
Duru, Firat
Emmenegger, Vishalini
Cyganek, Lukas
Hierlemann, Andreas
Uluşan, Hasan
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
9
views
1
downloads
Cite This
Introduction In recent years, high-density microelectrode arrays (HD-MEAs) have emerged as a valuable tool in preclinical research for characterizing the electrophysiology of human induced pluripotent stem-cell-derived cardiomyocytes (iPSC-CMs). HD-MEAs enable the capturing of both extracellular and intracellular signals on a large scale, while minimizing potential damage to the cell. However, despite technological advancements of HD-MEAs, there is a lack of effective data-analysis platforms that are capable of processing and analyzing the data, particularly in the context of cardiac arrhythmias and drug testing.Methods To address this need, we introduce CardioMEA, a comprehensive data-analysis platform designed specifically for HD-MEA data that have been obtained from iPSCCMs. CardioMEA features scalable data processing pipelines and an interactive web-based dashboard for advanced visualization and analysis. In addition to its core functionalities, CardioMEA incorporates modules designed to discern crucial electrophysiological features between diseased and healthy iPSC-CMs. Notably, CardioMEA has the unique capability to analyze both extracellular and intracellular signals, thereby facilitating customized analyses for specific research tasks.Results and discussion We demonstrate the practical application of CardioMEA by analyzing electrophysiological signals from iPSC-CM cultures exposed to seven antiarrhythmic drugs. CardioMEA holds great potential as an intuitive, userfriendly platform for studying cardiac diseases and assessing drug effects.
URI
https://hdl.handle.net/11511/113646
Journal
FRONTIERS IN PHYSIOLOGY
DOI
https://doi.org/10.3389/fphys.2024.1472126
Collections
Department of Electrical and Electronics Engineering, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
J. Lee et al., “CardioMEA: comprehensive data analysis platform for studying cardiac diseases and drug responses,”
FRONTIERS IN PHYSIOLOGY
, vol. 15, pp. 0–0, 2024, Accessed: 00, 2025. [Online]. Available: https://hdl.handle.net/11511/113646.